Skip to content

Generic selectors
Correspondance exacte uniquement
Recherche dans le titre
Rechercher dans le contenu
Post Type Selectors
ELA International (ancien)
ELA International (ancien)
Secondary Navigation Menu
Menu
  • News
    • Archives News
  • Missions
    • Research funding
    • Support the families
    • To raise public awareness
    • International development
  • Organization
    • Our history
    • Our organization
    • The members
    • ELA international’s members
    • Advisory Board
  • The different forms of leukodystrophy
    • Introduction
    • Diseases
      • ALD/AMN
      • Undefined leukodystrophies
      • Canavan disease
      • Krabbe disease
      • Refsum disease
      • Alexander disease
      • MLC disease
      • MLD
      • PMD and other hypomyelinating leukodystrophies
      • Aicardi-Goutières syndrome
      • CACH syndrome
      • LTBL
    • The expert centers
      • Reference Center for Neurogenetic Diseases in Children and Adults
      • Reference Centre for Leukodystrophies in Robert-Debré
      • Reference Center for Leukodystrophies in Bicêtre
  • Research
    • Scientific Committee
    • ELA Team
    • Main steps
    • Annual Call for Proposals
    • Clinical Trial FOA
    • Funded Research Projects
    • Clinical Studies
    • Leuconnect
      • Leuconnect
      • Studies online
      • Découvrez la messagerie de Leuconnect
    • Scientific events
      • Families/Researchers Meeting
      • Symposium
    • European Joint Programme on Rare Diseases (EJP Rare Diseases)
    • Additional documentation
    • Partners
  • Support
    • Become a donor
    • Mobilise
    • They support us
    • Become partner
    • Online shop
    • Contact
  • Français
  • English (UK)

Netherlands

Newborn screening of X-linked adrenoleukodystrophy (ALD) becomes part of program in the Netherlands

2023-05-10

On April 18th, 2023, the State Secretary of the Ministry of Health, Welfare and Sport of the Netherlands decided to add the metabolic disease ALD to the newborn screening program to identify boys with adrenoleukodystrophy. Screening will start on October 1st, 2023. Most boys with adrenoleukodystrophy will develop severe damageRead More →

© ELA 2023